| Body na spoluautora | Body za publikaci pro MU | Odkaz ISVaV | | 3,77 | 26,39 | Efficacious but insidious: A retrospective analysis of fludarabine induced myelotoxicity using long term culture initiating cells in 100 follicular lymphoma patients
|
| 0,40 | 2,81 | Možnosti ochrany reprodukčních funkcí u žen podstupujících chemoterapii pro hematologickou malignitu.
|
| 0,47 | 2,81 | Kryokonzervace ovariální tkáně: šance k záchraně fertility u ženy s rakovinou
|
| 0,00 | 0,00 | Reproductive function protection in women undergoing chemotherapy for hematological malignancy
|
| 1,05 | 8,42 | Poškození fertility a možnosti její ochrany u pacientů podstupujících systémovou léčbu chemoterapií pro Hodgkinův lymfom, literární přehled a vlastní zkušenosti
|
| 0,00 | 0,00 | . Reproductive function protection in women undergoing chemotherapy for hematological malignancy.
|
| 0,00 | 0,00 | Damage to ovarian functions in young women treated with ABVD and BEACOPP chemotherapy for Hodgkin lymfoma
|
| 0,70 | 5,62 | Fertility preservation strategies in women undergoing chemotherapy for haematological malignancy.
|
| 0,00 | 0,00 | Gonadal protection with GnRH analogues during chemotherapy cytotoxic dose derived cohort study (OVARONKO).
|
| 1,99 | 13,90 | Gonadal protection with GnRH analogues during chemotherapy – cytotoxic dose derived cohort study (OVARONKO)
|
| 9,13 | 73,02 | Prevention of ovarian function damage with gonadoliberine analogues during chemotherapy in Hodgkin lymphoma patients
|
| 1,78 | 8,90 | Value of [F-18]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: The end of a dilemma?
|
| 12,81 | 102,48 | Gonadoliberine analogues administration for ovarian function protection during chemotherapy
|
| 0,37 | 3,00 | "DNA mikročipy (microarrays) v diagnostice folikulárního lymfomu: cesta k terapii ""šité na míru"" nebo slepá ulička?"
|
| 0,70 | 5,62 | Kryokonzervace ovariální tkáně - šance na záchranu fertility žen s rakovinou
|
| 0,00 | 0,00 | Ovarian function preservation dutiny chemotherapy with gonadoliberine analogues
|
| 0,00 | 0,00 | Prevention of ovarian damage during chemotherapy by gonadoliberine analogues administration.
|
| 0,00 | 0,00 | Ovarian tissue cryopreservation - new opportunity to preserve fertility in female cancer patients
|
| 0,00 | 0,00 | Prevence poškození ovariálních funkcí aplikací analog gonadoliberinu u pacientek léčených pro Hodgkinův lymfom
|
| 0,00 | 0,00 | Prevention of ovarian damage during chemotherapy by gonadoliberine analogues administration
|
| 0,00 | 0,00 | Prevention of ovarian damage during chemotherapy by gonadoliberine analogues administration
|
Back
(c) Michal Bulant, 2011